Comparison of anti-A and/or anti-B antibody at day +30 after bone marrow hematopoietic stem cell transplantation or peripheral blood hematopoietic stem cell transplantation
| . | BMHSCT recipients N = 28 . | PBHSCT recipients N = 21 . | P . |
|---|---|---|---|
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 11) | 3 (11%) | 8 (38%) | |
| No (N = 38) | 25 (89%) | 13 (62%) | .04 |
| ABO identical | |||
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 4) | 1 (7%) | 3 (30%) | |
| No (N = 21) | 14 (93%) | 7 (70%) | |
| ABO minor mismatch alone | |||
| Increased anti-A and/or anti-B Ab | .103-150 | ||
| Yes (N = 6) | 1 (13%) | 5 (71%) | |
| No (N = 9) | 7 (87%) | 2 (29%) | |
| ABO major (± minor) mismatch | |||
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 1) | 1 (20%) | 0 | |
| No (N = 8) | 4 (80%) | 4 (100%) | |
| Presence of anti-RBC Ag allo-Ab (other than A, B Ag) | |||
| Yes (N = 3) | 0 (0%) | 3 (14%) | |
| (anti-Cw, anti-e, anti-E) | |||
| No (N = 46) | 28 (100%) | 18 (86%) | .07 |
| . | BMHSCT recipients N = 28 . | PBHSCT recipients N = 21 . | P . |
|---|---|---|---|
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 11) | 3 (11%) | 8 (38%) | |
| No (N = 38) | 25 (89%) | 13 (62%) | .04 |
| ABO identical | |||
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 4) | 1 (7%) | 3 (30%) | |
| No (N = 21) | 14 (93%) | 7 (70%) | |
| ABO minor mismatch alone | |||
| Increased anti-A and/or anti-B Ab | .103-150 | ||
| Yes (N = 6) | 1 (13%) | 5 (71%) | |
| No (N = 9) | 7 (87%) | 2 (29%) | |
| ABO major (± minor) mismatch | |||
| Increased anti-A and/or anti-B Ab | |||
| Yes (N = 1) | 1 (20%) | 0 | |
| No (N = 8) | 4 (80%) | 4 (100%) | |
| Presence of anti-RBC Ag allo-Ab (other than A, B Ag) | |||
| Yes (N = 3) | 0 (0%) | 3 (14%) | |
| (anti-Cw, anti-e, anti-E) | |||
| No (N = 46) | 28 (100%) | 18 (86%) | .07 |
Ag indicates antigen; for other abbreviations, see Tables 1 and2.
Breslow test for homogeneity.